vimarsana.com

Polpharma Biologics Announces FDA Approval of Tyruko® -  First And Only Approved Biosimilar to Tysabri®* for Relapsing Forms of Multiple SclerosisAMSTERDAM, The Netherlands, August 25, 2023 / B3C newswire / -- Polpharma Biologics, an international biotech company dedicated to the development and ma...

Related Keywords

Netherlands ,Amsterdam ,Noord Holland ,Michael Soldan ,Polpharma Biologics ,European Medicines Agency ,Polpharma Biologics Group ,Drug Administration ,Polpharma Biologics Announces ,First And Only Approved Biosimilar ,Relapsing Forms ,Chief Executive Officer ,Risk Evaluation ,Mitigation Strategy ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.